glp 1 gut microbiota A sympathetic brake on GLP-1 release: Neuron Implement enhanced artificial “enteroendocrine L

A critical consideration is that diabetes itself substantially increases gastroparesis riskaffecting up to 5% of patients with type 1 diabetes and 1% with type 2 diabetes

The employer backlash While Medicare opened the door, commercial insurance is quietly closing it

C/EBP, CCAAT/enhancer binding protein

The cost of GLP-1 medications can be high, often ranging from $500 to $1,000 per month

This is a question our team gets a lot in 2026

Litigation over Ozempic and Wegovy has expanded beyond gastrointestinal injuries, with over 30 plaintiffs now alleging that use of the drugs led to vision loss caused by nonarteritic anterior ischemic optic neuropathy (NAION), a condition that can cause permanent blindness